| Name | Ascendis Pharma AS |
|---|---|
| ISIN | US04351P1012 |
| Country | USA |
| Currency | USD |
| Exchange | NASDAQ |
| LEI | 549300B66JN3W3J8GH73 |
Who is buying and selling ASND shares/equities?
| Date | <ETF ISIN/Name | Action | Num Shares Bought/Sold | Book Value of Trade |
|---|---|---|---|---|
| 2024-11-18 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | SELL | -1,485 @122 | -181,170 |
| 2024-11-18 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | SELL | -1,485 @122 | -181,170 |
| 2024-11-08 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | SELL | -99 @124.33 | -12,309 |
| 2024-11-08 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | SELL | -99 @124.33 | -12,309 |
| 2024-10-21 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | SELL | -99 @128.66 | -12,737 |
| 2024-10-21 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | SELL | -99 @128.66 | -12,737 |